Satb2 determines miRNA expression and long-term memory in the adult central nervous system

  1. Clemens Jaitner
  2. Chethan Reddy
  3. Andreas Abentung
  4. Nigel Whittle
  5. Dietmar Rieder
  6. Andrea Delekate
  7. Martin Korte
  8. Gaurav Jain
  9. Andre Fischer
  10. Farahnaz Sananbenesi
  11. Isabella Cera
  12. Nicolas Singewald
  13. Georg Dechant  Is a corresponding author
  14. Galina Apostolova  Is a corresponding author
  1. Medical University of Innsbruck, Austria
  2. University of Innsbruck, Austria
  3. Technical University Braunschweig, Germany
  4. German Center for Neurodegenerative Diseases, Germany

Abstract

SATB2 is a risk locus for schizophrenia and encodes a DNA-binding protein that regulates higher-order chromatin configuration. In the adult brain Satb2 is almost exclusively expressed in pyramidal neurons of two brain regions important for memory formation, the cerebral cortex and the CA1-hippocampal field. Here we show that Satb2 is required for key hippocampal functions since deletion of Satb2 from the adult mouse forebrain prevents the stabilization of synaptic long-term potentiation and markedly impairs long-term fear and object discrimination memory. At molecular level, we find that synaptic activity and BDNF up-regulate Satb2, which itself binds to promoters of coding and non-coding genes. Satb2 controls the hippocampal levels of a large cohort of miRNAs, many of which are implicated in synaptic plasticity and memory formation. Together, our findings demonstrate that Satb2 is critically involved in long-term plasticity processes in the adult forebrain that underlie the consolidation and stabilization of context-linked memory.

Data availability

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Clemens Jaitner

    Institute for Neuroscience, Medical University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  2. Chethan Reddy

    Institute for Neuroscience, Medical University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  3. Andreas Abentung

    Institute for Neuroscience, Medical University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  4. Nigel Whittle

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  5. Dietmar Rieder

    Division of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  6. Andrea Delekate

    Zoological Institute, Technical University Braunschweig, Braunschweig, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8887-0806
  7. Martin Korte

    Zoological Institute, Technical University Braunschweig, Braunschweig, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Gaurav Jain

    Research group for Epigenetics in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Andre Fischer

    Research group for Epigenetics in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Farahnaz Sananbenesi

    Research group for Complex Neurodegenerative Disorders, German Center for Neurodegenerative Diseases, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Isabella Cera

    Institute for Neuroscience, Medical University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  12. Nicolas Singewald

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  13. Georg Dechant

    Institute for Neuroscience, Medical University of Innsbruck, Innsbruck, Austria
    For correspondence
    georg.dechant@i-med.ac.at
    Competing interests
    The authors declare that no competing interests exist.
  14. Galina Apostolova

    Institute for Neuroscience, Medical University of Innsbruck, Innsbruck, Austria
    For correspondence
    galina.apostolova@i-med.ac.at
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2682-4385

Funding

Austrian Science Fund (P25014-B24)

  • Galina Apostolova

Austrian Science Fund (DK W1206)

  • Georg Dechant

Austrian Science Fund (DK W1206)

  • Nicolas Singewald

Deutsche Forschungsgemeinschaft

  • Martin Korte

Innsbruck Medical University (MUI-Start 2010012004)

  • Galina Apostolova

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experimentation procedures were approved by the Austrian Animal Experimentation Ethics Board (Permit Number: GZ: BMWFW-66.011/0078-WF/II/3b/2014)

Copyright

© 2016, Jaitner et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,574
    views
  • 835
    downloads
  • 65
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Clemens Jaitner
  2. Chethan Reddy
  3. Andreas Abentung
  4. Nigel Whittle
  5. Dietmar Rieder
  6. Andrea Delekate
  7. Martin Korte
  8. Gaurav Jain
  9. Andre Fischer
  10. Farahnaz Sananbenesi
  11. Isabella Cera
  12. Nicolas Singewald
  13. Georg Dechant
  14. Galina Apostolova
(2016)
Satb2 determines miRNA expression and long-term memory in the adult central nervous system
eLife 5:e17361.
https://doi.org/10.7554/eLife.17361

Share this article

https://doi.org/10.7554/eLife.17361

Further reading

    1. Chromosomes and Gene Expression
    Carmina Lichauco, Eric J Foss ... Antonio Bedalov
    Research Article

    The association between late replication timing and low transcription rates in eukaryotic heterochromatin is well known, yet the specific mechanisms underlying this link remain uncertain. In Saccharomyces cerevisiae, the histone deacetylase Sir2 is required for both transcriptional silencing and late replication at the repetitive ribosomal DNA (rDNA) arrays. We have previously reported that in the absence of SIR2, a de-repressed RNA PolII repositions MCM replicative helicases from their loading site at the ribosomal origin, where they abut well-positioned, high-occupancy nucleosomes, to an adjacent region with lower nucleosome occupancy. By developing a method that can distinguish activation of closely spaced MCM complexes, here we show that the displaced MCMs at rDNA origins have increased firing propensity compared to the nondisplaced MCMs. Furthermore, we found that both activation of the repositioned MCMs and low occupancy of the adjacent nucleosomes critically depend on the chromatin remodeling activity of FUN30. Our study elucidates the mechanism by which Sir2 delays replication timing, and it demonstrates, for the first time, that activation of a specific replication origin in vivo relies on the nucleosome context shaped by a single chromatin remodeler.

    1. Chromosomes and Gene Expression
    2. Structural Biology and Molecular Biophysics
    Liza Dahal, Thomas GW Graham ... Xavier Darzacq
    Research Article

    Type II nuclear receptors (T2NRs) require heterodimerization with a common partner, the retinoid X receptor (RXR), to bind cognate DNA recognition sites in chromatin. Based on previous biochemical and overexpression studies, binding of T2NRs to chromatin is proposed to be regulated by competition for a limiting pool of the core RXR subunit. However, this mechanism has not yet been tested for endogenous proteins in live cells. Using single-molecule tracking (SMT) and proximity-assisted photoactivation (PAPA), we monitored interactions between endogenously tagged RXR and retinoic acid receptor (RAR) in live cells. Unexpectedly, we find that higher expression of RAR, but not RXR, increases heterodimerization and chromatin binding in U2OS cells. This surprising finding indicates the limiting factor is not RXR but likely its cadre of obligate dimer binding partners. SMT and PAPA thus provide a direct way to probe which components are functionally limiting within a complex TF interaction network providing new insights into mechanisms of gene regulation in vivo with implications for drug development targeting nuclear receptors.